HIA
RMD icon

HFM Investment Advisors’s ResMed RMD Stock Holding History

HFM Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$898 Buy
4
+1
+33% +$249 ﹤0.01% 451
2025
Q4 		$723 Sell
3
-1
-25% -$256 ﹤0.01% 570
2025
Q3 		$1.09K Hold
4
– – ﹤0.01% 330
2025
Q2 		$1.03K Buy
4
+3
+300% +$716 ﹤0.01% 341
2025
Q1 		$224 Buy
+1
New +$233 ﹤0.01% 587

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HFM Investment Advisors's RMD Position: Q1 2026 in Review

HFM Investment Advisors increased its ResMed (RMD) stake by 33% in Q1 2026, buying an estimated $249 and bringing the position to 4 shares worth $898. The position accounts for ﹤0.01% of the portfolio, ranked #451.

HFM Investment Advisors first reported a position in RMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.09K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • HFM Investment Advisors held 4 shares of ResMed worth $898 as of Q1 2026.
  • HFM Investment Advisors bought 1 ResMed share in Q1 2026, an estimated $249.
  • ResMed made up ﹤0.01% of HFM Investment Advisors's portfolio in Q1 2026, its #451 holding.
  • HFM Investment Advisors first reported a position in ResMed in Q1 2025 and has held it in 5 quarters since.
  • HFM Investment Advisors's ResMed position peaked at $1.09K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on HFM Investment Advisors's 13F filing for Q1 2026, filed 1 May 2026.